Report Content

Chapter 1   Methodology

1.1    Definition and forecast parameters

1.1.1    Definitions

1.1.2    Methodology and forecast parameters

1.2    Data sources

1.3    References & sources

1.3.1    Secondary

1.3.2    Primary

Chapter 2   Executive Summary

2.1    Asia Pacific healthcare 3D printing industry summary, 2017 - 2028

2.1.1    Country trends

2.1.2    Product trends

2.1.3    Technology trends

2.1.4    End-use trends

Chapter 3   Industry Insights

3.1    Industry segmentation

3.2    Industry outlook, 2017 - 2028

3.3    Major factor analysis

3.3.1    Drivers

3.3.1.1   Technological advancements

3.3.1.2   Increasing trend for customized implants

3.3.1.3   Growing investment in R&D

3.3.2    Industry pitfall and challenges

3.3.2.1. High price associated with 3 D printing

3.3.2.2   Lack of skilled professionals

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    Competitive review, 2021

3.7    PEST analysis

Chapter 4   Asia Pacific Healthcare 3D Printing Market, By Product

4.1    Key trends in Asia Pacific healthcare 3D printing market, by product

4.2    Syringe based

4.2.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

4.3    Inkjet based

4.3.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

4.4    Laser based

4.4.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

4.5    Magnetic levitation

4.5.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

Chapter 5   Asia Pacific healthcare 3D printing Market, By Technology

5.1    Key trends in Asia Pacific healthcare 3D printing market, by technology

5.2    Fused deposition model

5.2.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

5.3    Selective laser sintering

5.3.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

5.4    Stereolithography

5.4.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

5.5    Others

5.5.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

Chapter 6   Asia Pacific healthcare 3D printing Market, By Application

6.1    Key trends in Asia Pacific healthcare 3D printing market, by application

6.2    Biosensor

6.2.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

6.3    Medical

6.3.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

6.3.2    Pharmaceutical

6.3.2.1   Market estimates and forecast, by country, 2017 - 2028 (USD Million)

6.3.3    Prosthetic and implants

6.3.3.1   Market estimates and forecast, by country, 2017 - 2028 (USD Million)

6.3.4    Tissue and organ generation

6.3.4.1   Market estimates and forecast, by country, 2017 - 2028 (USD Million)

6.4    Dental

6.4.1    Market estimates and forecast, by country, 2017 - 2028 (USD Million)

Chapter 7   Asia Pacific healthcare 3D printing Market, By Country

7.1    Key trends in Asia Pacific healthcare 3D printing market, by country

7.2    Japan

7.2.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.2.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.2.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.2.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.3    China

7.3.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.3.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.3.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.3.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.4    India

7.4.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.4.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.4.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.4.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.5    Australia

7.5.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.5.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.5.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.5.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.6    South Korea

7.6.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.6.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.6.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.6.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.7    Singapore

7.7.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.7.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.7.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.7.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.8    Thailand

7.8.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.8.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.8.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.8.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.9    Malaysia

7.9.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.9.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.9.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.9.3.1   Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

7.10    Australia

7.10.1    Market estimates and forecast, by product, 2017 - 2028 (USD Million)

7.10.2    Market estimates and forecast, by technology, 2017 - 2028 (USD Million)

7.10.3    Market estimates and forecast, by application, 2017 - 2028 (USD Million)

7.10.3.1    Market estimates and forecast, by medical application, 2017 - 2028 (USD Million)

Chapter 8   Company Profiles

8.1    Cyfuse Biomedical

8.1.1    Business overview

8.1.2    Financial data

8.1.3    Product landscape

8.1.4    Strategic outlook

8.2    3D Systems

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.3    Stratasys Ltd

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.4    Renishaw

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.5    Oventus Medical

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.6    Materialise

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.7    Carbon, Inc

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.8    SLM Solution

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.9    Imaginarium

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.10    Prodways Tech

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook